1. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest. 1993. 92:2577–2586.
2. Pope NS, Gould KG, Anderson DC, Mann DR. Effects of age and sex on bone density in the rhesus monkey. Bone. 1989. 10:109–112.
3. Johansson ED, Neill JD, Knobil E. Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology. 1968. 82:143–148.
4. Neill JD, Johansson ED, Knobil E. Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology. 1969. 84:45–48.
5. Jerome CP, Carlson CS, Register TC, Bain FT, Jayo MJ, Weaver DS, et al. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry. J Bone Miner Res. 1994. 9:527–540.
6. Jayo MJ, Jerome CP, Lees CJ, Rankin SE, Weaver DS. Bone mass in female cynomolgus macaques: a cross-sectional and longitudinal study by age. Calcif Tissue Int. 1994. 54:231–236.
7. Jerome CP, Carlson CS, Jayo MJ, Register TC, Weaver DS, Lees CJ, et al. Histomorphometric and mineral density fractionation studies of lumbar vertebrae of intact and ovariecto-mized (OVX) monkeys. Bone Miner. 1994. 26:275–278.
8. Jerome CP, Peterson PE. Nonhuman primate models in skeletal research. Bone. 2001. 29:1–6.
9. Itoh F, Kojima M, Furihata-Komatsu H, Aoyagi S, Kusama H, Komatsu H, et al. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate. J Bone Miner Res. 2002. 17:534–543.
10. Pavelka MS, Fedigan LM. Reproductive termination in femdle Japanese monkeys: A comparative life history perspective. Am J Phys Anthropol. 1999. 109:455–464.
11. Erben RG. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem. 1997. 45:307–313.
12. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987. 2:595–610.
13. Jerome CP, Lees CJ, Weaver DS. Development of osteopenia in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone. 1995. 17:403S–408S.
14. Jerome CP, Turner CH, Lees CJ. Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis). Calcif Tissue Int. 1997. 60:265–270.
15. Hotchkiss CE, Stavisky R, Nowak J, Brommage R, Lees CJ, Kaplan J. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys. Bone. 2001. 29:7–15.
16. Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, et al. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys. Bone. 1997. 20:355–364.
17. Lees CJ, Register TC, Turner CH, Wang T, Stancill M, Jerome CP. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys. Menopause. 2002. 9:320–328.
18. Brommage R, Hotchkiss CE, Lees CJ, Stancill MW, Hock JM, Jerome CP. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab. 1999. 84:3757–3763.